Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Molecular and Cellular Pathobiology

Identification of FoxM1/Bub1b Signaling Pathway as a Required Component for Growth and Survival of Rhabdomyosarcoma

Xiaolin Wan, Choh Yeung, Su Young Kim, Joseph G. Dolan, Vu N. Ngo, Sandra Burkett, Javed Khan, Louis M. Staudt and Lee J. Helman
Xiaolin Wan
Authors' Affiliations: Molecular Oncology Section, Oncogenomics Section, Pediatric Oncology Branch, Metabolism Branch, Center for Cancer Research, and Comparative Molecular Cytogenetics Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Choh Yeung
Authors' Affiliations: Molecular Oncology Section, Oncogenomics Section, Pediatric Oncology Branch, Metabolism Branch, Center for Cancer Research, and Comparative Molecular Cytogenetics Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Su Young Kim
Authors' Affiliations: Molecular Oncology Section, Oncogenomics Section, Pediatric Oncology Branch, Metabolism Branch, Center for Cancer Research, and Comparative Molecular Cytogenetics Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph G. Dolan
Authors' Affiliations: Molecular Oncology Section, Oncogenomics Section, Pediatric Oncology Branch, Metabolism Branch, Center for Cancer Research, and Comparative Molecular Cytogenetics Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vu N. Ngo
Authors' Affiliations: Molecular Oncology Section, Oncogenomics Section, Pediatric Oncology Branch, Metabolism Branch, Center for Cancer Research, and Comparative Molecular Cytogenetics Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Burkett
Authors' Affiliations: Molecular Oncology Section, Oncogenomics Section, Pediatric Oncology Branch, Metabolism Branch, Center for Cancer Research, and Comparative Molecular Cytogenetics Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javed Khan
Authors' Affiliations: Molecular Oncology Section, Oncogenomics Section, Pediatric Oncology Branch, Metabolism Branch, Center for Cancer Research, and Comparative Molecular Cytogenetics Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis M. Staudt
Authors' Affiliations: Molecular Oncology Section, Oncogenomics Section, Pediatric Oncology Branch, Metabolism Branch, Center for Cancer Research, and Comparative Molecular Cytogenetics Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lee J. Helman
Authors' Affiliations: Molecular Oncology Section, Oncogenomics Section, Pediatric Oncology Branch, Metabolism Branch, Center for Cancer Research, and Comparative Molecular Cytogenetics Core Facility, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/0008-5472.CAN-12-1991
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

We identified Bub1b as an essential element for the growth and survival of rhabdomyosarcoma (RMS) cells using a bar-coded, tetracycline-inducible short hairpin RNA (shRNA) library screen. Knockdown of Bub1b resulted in suppression of tumor growth in vivo, including the regression of established tumors. The mechanism by which this occurs is via postmitotic endoreduplication checkpoint and mitotic catastrophe. Furthermore, using a chromatin immunoprecipitation assay, we found that Bub1b is a direct transcriptional target of Forkhead Box M1 (FoxM1). Suppression of FoxM1 either by shRNA or the inhibitor siomycin A resulted in reduction of Bub1b expression and inhibition of cell growth and survival. These results show the important role of the Bub1b/FoxM1 pathway in RMS and provide potential therapeutic targets. Cancer Res; 72(22); 1–11. ©2012 AACR.

  • Received May 22, 2012.
  • Revision received September 6, 2012.
  • Accepted September 7, 2012.
  • ©2012 American Association for Cancer Research.
Next
Back to top

Published OnlineFirst November 8, 2012
doi: 10.1158/0008-5472.CAN-12-1991

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of FoxM1/Bub1b Signaling Pathway as a Required Component for Growth and Survival of Rhabdomyosarcoma
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Identification of FoxM1/Bub1b Signaling Pathway as a Required Component for Growth and Survival of Rhabdomyosarcoma
Xiaolin Wan, Choh Yeung, Su Young Kim, Joseph G. Dolan, Vu N. Ngo, Sandra Burkett, Javed Khan, Louis M. Staudt and Lee J. Helman
Cancer Res November 8 2012 DOI: 10.1158/0008-5472.CAN-12-1991

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Identification of FoxM1/Bub1b Signaling Pathway as a Required Component for Growth and Survival of Rhabdomyosarcoma
Xiaolin Wan, Choh Yeung, Su Young Kim, Joseph G. Dolan, Vu N. Ngo, Sandra Burkett, Javed Khan, Louis M. Staudt and Lee J. Helman
Cancer Res November 8 2012 DOI: 10.1158/0008-5472.CAN-12-1991
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • TRβ2 Bypasses Rb-Dependent Proliferation in RB1−/− Cells
  • DHHC3 Regulates Breast Tumor Growth In Vivo
  • Role of Fibroblasts in Pathogenesis of Fibroids
Show more Molecular and Cellular Pathobiology
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement